Key statistics dashboard for 10x Genomics, Inc. (TXG). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Headquartered in Pleasanton, California, 10x Genomics, Inc. (founded in 2012 and known as 10X Technologies, Inc. until November 2014) is a prominent life science technology company. The firm specializes in creating and distributing sophisticated instrumentation, essential consumables, and software designed for in-depth analysis of biological systems. Its market presence extends globally, covering North America, Europe, the Middle East, Africa, China, and the Asia Pacific.
Stock Data
| Price | $97.74 |
| Market Cap | $12.4B |
| Enterprise Value | $11.98B |
| Beta | 2.17 |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | -165.66 |
| Price / Book | 15.39 |
| P/S | 20.11 |
| EV/EBITDA | 427.97 |
| EV/Sales | 19.43 |
| EV/FCF | 98.69 |
| P/FCF | 102.18 |
| Earnings Yield | -0.59% |
| FCF Yield | 0.98% |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 70.03% |
| EBIT Margin | -1.34% |
| EBITDA Margin | 4.54% |
| Operating Margin | -14.33% |
| Net Margin | -12.18% |
| Return on Equity | -9.33% |
| Return on Assets | -7.29% |
| Return on Invested Capital | -9.57% |
| Return on Capital Employed | -9.70% |
Financial Health
| Current Ratio | 5.69 |
| Quick Ratio | 5.25 |
| Cash Ratio | 4.24 |
| Debt / Equity | 0.10 |
| Debt / Assets | 7.65% |
| Net Debt / EBITDA | -15.13 |
| Interest Coverage | -29,461.33 |
| Piotroski F-Score | 4 |
| Altman Z-Score | 3.83 |
Per-Share Data
| Revenue per share | 4.75 |
| Book Value per share | 6.35 |
| Cash per share | 4.25 |
| FCF per share | 0.93 |
| Tangible Book Value per share | 5.83 |
| Dividend per share | 0.00 |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 10 |
| Hold | 11 |
| Sell | 1 |
| Strong Sell | 0 |
| Total analysts | 22 |
| Avg rating (1-5) | 0.41 |
Related companies: CERT · GRDN · JANX · NUVB · OMCL · OMDA · PGNY
Explore sector: Healthcare · Biotechnology
More sections of TXG: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks